Inhibikase Therapeutics shares owned by IFP Advisors
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by IFP Advisors
from 13F filings
Historical chart of IFP Advisors investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by IFP Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by IFP Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $5 | 3 | 1.67 |